Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-30

FDA Approved: CHLORTHALIDONE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved an original application for chlorthalidone from Rising Pharma Holdings, Inc., a generic diuretic indicated for hypertension and edema (including ed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorthalidone (chlorthalidone)

Snippet

ORIG AP for CHLORTHALIDONE (CHLORTHALIDONE)